High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines
- 15 January 1996
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 116 (1) , 115-119
- https://doi.org/10.1016/0303-7207(95)03697-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cyclins and cyclin-dependent kinases: a biochemical viewBiochemical Journal, 1995
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.The EMBO Journal, 1995
- p53 and Rb: their cellular rolesCurrent Opinion in Cell Biology, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid glandThe Journal of Pathology, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993